UBS Group’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Sell |
86,588
-115,597
| -57% | -$2.52M | ﹤0.01% | 3872 |
|
|
2025
Q1 | $3.74M | Buy |
202,185
+129,492
| +178% | +$2.39M | ﹤0.01% | 3191 |
|
|
2024
Q4 | $1.94M | Buy |
72,693
+54,057
| +290% | +$1.44M | ﹤0.01% | 3743 |
|
|
2024
Q3 | $438K | Buy |
18,636
+6,651
| +55% | +$156K | ﹤0.01% | 4188 |
|
|
2024
Q2 | $222K | Buy |
11,985
+2,090
| +21% | +$38.8K | ﹤0.01% | 4474 |
|
|
2024
Q1 | $177K | Buy |
+9,895
| New | +$177K | ﹤0.01% | 4797 |
|